Safety and Efficacy of 333369 in the Treatment of Partial Epilepsy

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

February 28, 2005

Primary Completion Date

May 31, 2006

Study Completion Date

May 31, 2006

Conditions
Refractory Epilepsy
Interventions
DRUG

RWJ-333369

Trial Locations (61)

Unknown

Birmingham

Huntsville

Mobile

Northport

Phoenix

Little Rock

Irvine

Northridge

Sacramento

Fort Collins

Wilmington

Decatur

Lexington

Louisville

Baton Rouge

Golden Valley

Saint Paul

Chesterfield

Cincinnati

Portland

Philadelphia

Sellersville

Nashville

Dallas

El Paso

Bennington

Charlottesville

Roanoke

Madison

Ciudad de Buenos Aires

Córdoba

Salta

Budapest

Debrecen

Győr

Pécs

Zalaegerszeg-Pozva

Breda

Heemstede

Heeze

Rotterdam

Gdansk

Katowice

Kielce

Krakow

Lublin

Mosina

Warsaw

Zabrze

Moscow

Saint Petersburg

Samara

Barcelona

Madrid

Málaga

Pamplona

Glasgow

Middlesbrough

Northampton

Oxford

Reading

All Listed Sponsors
lead

SK Life Science, Inc.

INDUSTRY

NCT00228969 - Safety and Efficacy of 333369 in the Treatment of Partial Epilepsy | Biotech Hunter | Biotech Hunter